Immune-Cell-Based Therapy for COVID-19: Current Status

Yiyuan Wang,Qinghe Liang,Fengsheng Chen,Jiehuang Zheng,Yan Chen,Ziye Chen,Ruopeng Li,Xiaojuan Li
DOI: https://doi.org/10.3390/v15112148
2023-10-25
Viruses
Abstract:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate and adaptive immune responses plays a crucial role in managing COVID-19. Cell therapy has recently emerged as a promising strategy to modulate the immune system, offering immense potential for the treatment of COVID-19 due to its customizability and regenerative capabilities. This review provides an overview of the various subsets of immune cell subsets implicated in the pathogenesis of COVID-19 and a comprehensive summary of the current status of immune cell therapy in COVID-19 treatment.
virology
What problem does this paper attempt to address?